A randomized controlled comparative study of efficacy of oral metronidazole versus oral tinidazole in amebic liver abscess
DOI:
https://doi.org/10.18203/2349-2902.isj20253840Keywords:
Amebic liver abscess, Metronidazole, TinidazoleAbstract
Background: Amebic liver abscess (ALA), a significant complication of amebiasis, is commonly treated with anti-amebic drugs like metronidazole and tinidazole. This randomized controlled study aimed to compare the efficacy and safety of oral metronidazole and tinidazole in treating ALA.
Methods: Sixty patients with radiologically confirmed right lobe ALA were randomized into two groups: Group A received metronidazole (30-40 mg/kg/day in three divided doses), and Group B received tinidazole (50 mg/kg/day in divided doses). Baseline demographic, clinical, and laboratory parameters were comparable between the groups. Primary outcomes included the time to 50% reduction in pain and fever resolution, while secondary outcomes assessed drug tolerability, the need for additional antibiotics, and abscess drainage.
Results: Both groups demonstrated significant symptom resolution over 96 hours, with comparable reductions in pain (assessed by the Visual Analog Scale) and fever. None of the patients required abscess drainage or experienced complications during the study period. Tinidazole showed similar efficacy to metronidazole, with slightly better tolerability. Both drugs achieved significant clinical and radiological improvements, and there were no statistically significant differences in outcomes between the two groups.
Conclusions: This study confirms that both metronidazole and tinidazole are effective and safe for treating uncomplicated ALA. Tinidazole, with its prolonged bioavailability and fewer side effects, is a viable alternative to metronidazole.
Metrics
References
Hategekimana F, Saha S, Chaturvedi A. Amoebiasis transmission and life cycle: a continuous state description by virtue of existence and uniqueness. Glob J Pure Appl Math. 2016;12(1):375-90.
Akgun Y, Tacyildiz IH, Celik Y. Amebic liver abscess: changing trends over 20 years. World J Surg. 1999;23(1):102-6. DOI: https://doi.org/10.1007/s002689900573
Khokhani RC, Garud AD, Deodhar KP, Sureka SB, Kulkarni M, Damle VB. Treatment of amoebic liver abscess with tinidazole and metronidazole. Drugs. 1978;15(Suppl 1):23-5. DOI: https://doi.org/10.2165/00003495-197800151-00005
Sharma N, Sharma A, Varma S, Lal A, Singh V. Amoebic liver abscess in the medical emergency of a North Indian hospital. BMC Research Notes. 2010;3(1):21. DOI: https://doi.org/10.1186/1756-0500-3-21
Simjee AE, Wittenberg DF, et al. Tinidazole versus metronidazole in the treatment of amebic liver abscess. Gut. 1977; 18:335-337.
Kale SR, Shah SR, et al. Indications for aspiration in amebic liver abscess. Journal of Tropical Medicine and Hygiene. 1989; 92:141-145.
Mathur et al. Randomized control trial of tinidazole and metronidazole for the treatment of amebic liver abscess. Indian Journal of Surgery. 1998.
Goel A, et al. A comparative study of metronidazole and nitazoxanide in ALA. Gastroenterology Journal. 2004.